Abstract:Objective To explore the distribution characteristics of islet autoantibodies and other organ-specific autoantibodies in type 1 diabetes mellitus (T1DM) patients, and the correlation between organ-specific autoantibodies and clinical features. Methods A total of 205 newly diagnosed T1DM patients and 170 healthy controls were recruited in this study from the Second Xiangya Hospital of Central South University between Jan. 2015 and Dec. 2017. Glutamic acid decarboxylase antibody (GADA), insulinoma antigen 2 antibody (IA-2A), zinc transporter 8 antibody (ZnT8A) and other organ-specific autoantibodies, including thyroid peroxidase antibody (TPOA), thyroglobulin antibody (TGA), tissue transglutaminase antibody (tTGA) and 21-hydroxylase antibody (21-OHA) were detected by radioligand assay. In antibody-positive patients the function of thyroid and adrenal cortex was further examined; the coexistence of islet antibodies with other organ-specific autoantibodies, and the correlation between organ-specific antibodies and clinical characteristics were analyzed. Chi-square test, one-way analysis of variance and non-parametric test were used for statistical analysis. Results (1) The positive rates of GADA, IA-2A and ZnT8A in patients with T1DM were significantly higher than those in healthy controls [70.2％(144/205) vs 0.6％(1/170), 42.9％(88/205) vs 0 and 30.7％(63/205) vs 0 (0/170), χ2=190.131, 95.357, 62.792, respectively, all P<0.05]. (2) The positive rates of TPOA, TGA and 21-OHA in patients with T1DM were higher than those in healthy controls (24.9％vs 7.6％, 18.5％vs 5.9％, 2.9％vs 0,χ2=19.493, 13.332, 3.375, respectively, all P<0.05). However, there was no significant difference in the positive rate of tTGA (P>0.05). (3) In T1DM patients the detections of combining various islet autoantibodies (GADA+IA-2A+ZnT8A) could increase the positive rate to 82.9％. (4) T1DM patients with positive GADA and IA-2A were more likely to have positive TPOA and TGA antibodies, patients with positive IA-2A were more likely to have positive tTGA antibodies, and patients with two or more islet autoantibodies were more likely to have positive TPOA and TGA antibodies. (5) The proportion of T1DM patients with Graves'disease was higher than that of healthy controls (4.4％ vs 0.6％, P<0.05). Conclusions T1DM patients are prone to merge other organ-specific autoantibodies. It is of great clinical significance to screen other organ specific autoantibodies, especially in T1DM patients with positive polyantibodies.

Screening of Diabetes-Associated Autoantigens and Serum Antibody Profiles by Phage Display System

Screening and identification of human ZnT8-specific single-chain variable fragment (scFv) from type 1 diabetes phage display library

Triple Chimeric Islet Autoantigen IA2–ZnT8WR to Facilitate Islet Autoantibody Determination

Analysis of clinical features of type 1 diabetes patients with positive autoantibodies from different pancreatic island

SERS-based Detection of Early Type 1 Diabetes Mellitus Biomarkers: Glutamate Decarboxylase Antibody and Insulin Autoantibody

Cloning,Expression and Diagnostic Evaluation of the Fragments of Human Protein Tyrosine Phosphatase-Like Protein IA-2

Use of a glycomics array to establish the anti-carbohydrate antibody repertoire in type 1 diabetes

Identification of Insulin Mimetics from a Phage-displayed Library

Screening for Potential Serum-Based Proteomic Biomarkers for Human Type 2 Diabetes Mellitus Using Maldi-Tof Ms

Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay

Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes

Discordant association of islet autoantibodies with high-risk HLA genes in Chinese type 1 diabetes.

[Expression of Zinc Transporter 8 in Saccharomyces Cerevisiae and Its Antigenicity Analysis].

Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

Identification of Key Genes and Pathways in Peripheral Blood Mononuclear Cells of Type 1 Diabetes Mellitus by Integrated Bioinformatics Analysis

Expression and Identification of Type 1 Diabetes Associated Autoantigen IA-2

Significance of combined determination of three autoantibodies in early diagnosis of type 1 diabetes mellitus

Organ?specific autoantibodies in newly diagnosed type 1 diabetes mellitus patients

Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus

The Tryptic Peptides of Hemoglobin for Diagnosis of Type 2 Diabetes Mellitus Using Label-Free and Standard-Free LC-ESI-DMRM

Discovery and validation of glucose-sensitive peptide biomarkers from human serum albumin to diagnose type 2 diabetes mellitus